glycerophosphoinositol 4,5-bisphosphate has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balla, T; Bojjireddy, N; Botyanszki, J; Brown, R; Creech, D; Hammond, G; Harrison, S; Kemp, DC; Moore, C; Morrison, A; Peterson, R; Snead, M; Wilson, S | 1 |
1 other study(ies) available for glycerophosphoinositol 4,5-bisphosphate and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
Article | Year |
---|---|
Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate levels.
Topics: Animals; Cell Membrane; Chlorocebus aethiops; COS Cells; Enzyme Activation; Gene Targeting; HEK293 Cells; Hepatitis C; Humans; Mice; Mice, Transgenic; Minor Histocompatibility Antigens; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phosphotransferases (Alcohol Group Acceptor); Type C Phospholipases | 2014 |